Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 26, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Microtia
Interventions
COMBINATION_PRODUCT

AUR-201

Auricle and wedge subcutaneous implant consisting of 3-D printed autologous auricular sourced chondrocytes in a biopolymer matrix.

Trial Locations (1)

10021

RECRUITING

Romo Plastic Surgery, New York

Sponsors
All Listed Sponsors
lead

Auregen Biotherapeutics, SA

INDUSTRY